Organigram announces first phase of return-to-work strategy
May 14 2020 - 6:00AM
Business Wire
Company recalls approximately 50 employees to
core roles across organization
As it continues to monitor and assess the implications of the
COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX:
OGI), the parent company of Organigram Inc. (the “Company” or
“Organigram”), a leading licensed producer of cannabis, has
announced the first phase of its return-to-work strategy. The
Company has begun to implement a staggered return-to-work plan
effective May 13, 2020.
While the Province of New Brunswick currently remains in a state
of emergency, the Company has been in contact with government
officials to stay abreast of the province’s and provincial health
authority’s guidance related to safety and security. Indications
suggest conditions in New Brunswick continue to improve and the
province may begin to lift some of the current restrictions.
Similarly, Organigram has maintained an open dialogue with
jurisdictional and regional partners across the country through the
pandemic in order to assess and appropriately respond to consumer
demand.
“Throughout the pandemic, two critical factors have driven our
decision-making: the health of our employees and the long-term
wellness of our business,” says Greg Engel, CEO, Organigram.
“We are pleased to see early signals that conditions are
improving across the province as the provincial government has
shown strong leadership with their pandemic response. Recognizing
that there is still a long road ahead for Canadians and Canadian
businesses, we are optimistic as we initiate this first phase of
our return-to-work strategy. We also remain committed to thoughtful
and informed decisions as we continue to move our business
forward.”
The first phase of Organigram’s return-to-work strategy involves
recalling approximately 50 employees at the Moncton campus. These
employees will fill core roles across various departments that have
been deemed highest priority by the Organigram leadership team in
this initial phase. Subsequent phases of this plan will be
dependent upon public health and safety guidelines and the evolving
needs of Organigram’s business.
The safety of employees remains Organigram’s top priority.
Safety measures including an increased focus on sanitation and
social distancing, with additional hand sanitizing stations
throughout the facility, cleaning and sanitizing of high touch
surfaces, and additional cleaning in common areas implemented at
the outset of the pandemic remain in place at the Organigram
facility.
The Company’s leadership team will continue to monitor measures
and requirements as mandated by the Province of New Brunswick to
ensure a safe and healthy workplace for all employees.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Trailer Park Buds, Ankr Organics and
Trailblazer. Organigram's facility is located in Moncton, New
Brunswick and the Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that could change anticipated timelines for the return to
work strategy; including general risks related to COVID-19 and
risks as disclosed in the Company’s most recent annual information
form, management’s discussion and analysis and other Company
documents filed from time to time on SEDAR (see www.sedar.com) and
filed or furnished to the Securities and Exchange Commission on
EDGAR (see www.sec.gov). Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. Although the Company believes
that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable,
undue reliance should not be placed on such information and no
assurance can be given that such events will occur in the disclosed
time frames or at all. The forward-looking information included in
this news release are made as of the date of this news release and
the Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200514005252/en/
For Investor Relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries, please contact: Ray Gracewood Senior Vice
President, Marketing and Communications rgracewood@organigram.ca
(506) 645-1653
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024